EMORY UNIVERSITY
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1836-12-10
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.emory.edu
National Wilm's Tumor Study Late Effects
- Conditions
- Wilm's Tumor
- Interventions
- Other: none, screening only
- First Posted Date
- 2005-09-29
- Last Posted Date
- 2013-11-26
- Lead Sponsor
- Emory University
- Registration Number
- NCT00228696
- Locations
- 🇺🇸
Children's Healthcare of Atlanta, Atlanta, Georgia, United States
G-CSF PMRD: Granulocyte Colony Stimulating Factor (G-CSF) Stimulated Bone Marrow and In Vivo T-Cell Depletion in Patients With Hematologic Malignancies or Bone Marrow Failure Syndrome
- Conditions
- Hematologic Malignancies
- Interventions
- First Posted Date
- 2005-09-29
- Last Posted Date
- 2017-09-11
- Lead Sponsor
- Emory University
- Target Recruit Count
- 8
- Registration Number
- NCT00228813
- Locations
- 🇺🇸
Children's Healthcare of Atlanta/Emory University, Atlanta, Georgia, United States
Hepatoblastoma Biology Study and Tissue Bank
- Conditions
- Hepatoblastoma
- First Posted Date
- 2005-09-29
- Last Posted Date
- 2013-11-26
- Lead Sponsor
- Emory University
- Registration Number
- NCT00228683
- Locations
- 🇺🇸
Children's Healthcare of Atlanta, Atlanta, Georgia, United States
Effect of Sulfur Amino Acid Depletion and Acetaminophen on Plasma Glutatione
- Conditions
- Healthy
- First Posted Date
- 2005-09-29
- Last Posted Date
- 2009-01-30
- Lead Sponsor
- Emory University
- Target Recruit Count
- 15
- Registration Number
- NCT00228644
- Locations
- 🇺🇸
Emory University Hospital, Atlanta, Georgia, United States
Dietary Effects of Sulfur Amino Acids
- Conditions
- Healthy
- First Posted Date
- 2005-09-29
- Last Posted Date
- 2009-01-30
- Lead Sponsor
- Emory University
- Target Recruit Count
- 20
- Registration Number
- NCT00228618
- Locations
- 🇺🇸
Emory University Hospital, Atlanta, Georgia, United States
GVH 022P: Study Using Anti Tumor Necrosis Factor Antibody (Infliximab) for Treatment of Acute Graft Versus Host Disease
- Conditions
- Graft vs Host Disease
- First Posted Date
- 2005-09-29
- Last Posted Date
- 2009-06-30
- Lead Sponsor
- Emory University
- Registration Number
- NCT00228839
- Locations
- 🇺🇸
Children's Healthcare of Atlanta/Emory University, Atlanta, Georgia, United States
IMM 0212: Busulfan With Fludarabine and Antithymocyte Globulin as Preparative Therapy for Hematopoietic Stem Cell Transplant for the Treatment of Severe Congenital T-Cell Immunodeficiency
- Conditions
- T-Cell Immune Deficiency DiseasesSevere Combined Immunodeficiency
- First Posted Date
- 2005-09-29
- Last Posted Date
- 2009-06-30
- Lead Sponsor
- Emory University
- Registration Number
- NCT00228852
- Locations
- 🇺🇸
Children's Healthcare of Atlanta, Atlanta, Georgia, United States
Analysis of T-Cell Immune Reconstitution Following Allogeneic Hematopoietic BMT for Severe SCD
- Conditions
- Sickle Cell Disease
- First Posted Date
- 2005-09-29
- Last Posted Date
- 2014-05-26
- Lead Sponsor
- Emory University
- Target Recruit Count
- 7
- Registration Number
- NCT00228631
- Locations
- 🇺🇸
Children's Healthcare of Atlanta, Atlanta, Georgia, United States
Herpesvirus in Idiopathic Pulmonary Fibrosis
- Conditions
- Herpesvirus InfectionsLung Diseases
- First Posted Date
- 2005-09-29
- Last Posted Date
- 2017-05-11
- Lead Sponsor
- Emory University
- Target Recruit Count
- 41
- Registration Number
- NCT00228670
- Locations
- 🇺🇸
Emory University, Atlanta, Georgia, United States
The Effects of Cool Dialysate on the Sleep/Wake Cycle in Patients on Chronic Hemodialysis - "The Sleep Cool Study"
- Conditions
- End-stage Renal Disease
- Interventions
- Procedure: Cool Dialysate
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2014-02-12
- Lead Sponsor
- Emory University
- Target Recruit Count
- 58
- Registration Number
- NCT00218790
- Locations
- 🇺🇸
Emory affiliated hemodialysis units, Atlanta, Georgia, United States
🇺🇸Emory University affiliated hemodialysis units, Atlanta, Georgia, United States